Cargando…

Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study

Statin therapy may induce skeletal muscle damage ranging from myalgia to severe rhabdomyolysis. Our previous preclinical studies showed that statin treatment in rats involves the reduction of skeletal muscle ClC-1 chloride channel expression and related chloride conductance (gCl). An increase of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camerino, Giulia M., Musumeci, Olimpia, Conte, Elena, Musaraj, Kejla, Fonzino, Adriano, Barca, Emanuele, Marino, Marco, Rodolico, Carmelo, Tricarico, Domenico, Camerino, Claudia, Carratù, Maria R., Desaphy, Jean-François, De Luca, Annamaria, Toscano, Antonio, Pierno, Sabata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529355/ https://www.ncbi.nlm.nih.gov/pubmed/28798690 http://dx.doi.org/10.3389/fphar.2017.00500

Ejemplares similares

Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence
por: Camerino, Giulia Maria, et al.
Publicado: (2021)

Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional Evaluation
por: Camerino, Giulia Maria, et al.
Publicado: (2015)

Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options
por: Camerino, Giulia Maria, et al.
Publicado: (2019)

Oxytocin/Osteocalcin/IL-6 and NGF/BDNF mRNA Levels in Response to Cold Stress Challenge in Mice: Possible Oxytonic Brain-Bone-Muscle-Interaction
por: Camerino, Claudia, et al.
Publicado: (2019)

Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita
por: Portaro, Simona, et al.
Publicado: (2015)

Evaluation of Short and Long Term Cold Stress Challenge of Nerve Grow Factor, Brain-Derived Neurotrophic Factor, Osteocalcin and Oxytocin mRNA Expression in BAT, Brain, Bone and Reproductive Tissue of Male Mice Using Real-Time PCR and Linear Correlation Analysis
por: Camerino, Claudia, et al.
Publicado: (2018)

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016)

Taurine: the appeal of a safe amino acid for skeletal muscle disorders
por: De Luca, Annamaria, et al.
Publicado: (2015)

Changes in Expression and Cellular Localization of Rat Skeletal Muscle ClC-1 Chloride Channel in Relation to Age, Myofiber Phenotype and PKC Modulation
por: Conte, Elena, et al.
Publicado: (2020)

Nerve Growth Factor, Brain-Derived Neurotrophic Factor and Osteocalcin Gene Relationship in Energy Regulation, Bone Homeostasis and Reproductive Organs Analyzed by mRNA Quantitative Evaluation and Linear Correlation Analysis
por: Camerino, Claudia, et al.
Publicado: (2016)

In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography
por: Mele, Antonietta, et al.
Publicado: (2016)

Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity
por: De Bellis, Michela, et al.
Publicado: (2017)

Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk
por: Pierno, Sabata, et al.
Publicado: (2023)

Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies
por: Imbrici, Paola, et al.
Publicado: (2016)

Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle
por: Tarantino, Nancy, et al.
Publicado: (2022)

Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice
por: Pierno, Sabata, et al.
Publicado: (2013)

Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity
por: Camerino, Giulia Maria, et al.
Publicado: (2013)

Recent Advances in the Pathogenesis and Drug Action in Periodic Paralyses and Related Channelopathies
por: Tricarico, Domenico, et al.
Publicado: (2011)

Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential
por: De Bellis, Michela, et al.
Publicado: (2018)

Grand Challenge for Ion Channels: an Underexploited Resource for Therapeutics
por: Camerino, Diana Conte, et al.
Publicado: (2010)

Major channels involved in neuropsychiatric disorders and therapeutic perspectives
por: Imbrici, Paola, et al.
Publicado: (2013)

Splicing of the rSlo Gene Affects the Molecular Composition and Drug Response of Ca(2+)-Activated K(+) Channels in Skeletal Muscle
por: Dinardo, Maria Maddalena, et al.
Publicado: (2012)

Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin‐induced cachexia
por: Conte, Elena, et al.
Publicado: (2017)

Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
por: Manini, Arianna, et al.
Publicado: (2022)

Toward precision medicine in myotonic syndromes
por: De Bellis, Michela, et al.
Publicado: (2017)

In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia
por: Desaphy, Jean-François, et al.
Publicado: (2013)

Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs
por: Desaphy, Jean-François, et al.
Publicado: (2014)

Emerging Role of Calcium-Activated Potassium Channel in the Regulation of Cell Viability Following Potassium Ions Challenge in HEK293 Cells and Pharmacological Modulation
por: Tricarico, Domenico, et al.
Publicado: (2013)

Statins Neuromuscular Adverse Effects
por: Attardo, Silvia, et al.
Publicado: (2022)

Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy
por: Desaphy, Jean-François, et al.
Publicado: (2012)

S3.1 Are there ERT defined guidelines for Pompe disease?
por: Toscano, Antonio, et al.
Publicado: (2011)

S2.3 Therapeutic approaches in the late onset form of GSD II
por: Musumeci, Olimpia, et al.
Publicado: (2011)

Molecular Genetics Overview of Primary Mitochondrial Myopathies
por: Arena, Ignazio Giuseppe, et al.
Publicado: (2022)

Endocrine myopathies: clinical and histopathological features of the major forms
por: Rodolico, Carmelo, et al.
Publicado: (2020)

ClC-1 chloride channels: state-of-the-art research and future challenges
por: Imbrici, Paola, et al.
Publicado: (2015)

A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies
por: Musumeci, Olimpia, et al.
Publicado: (2020)

The large conductance Ca(2+) -activated K(+) (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases
por: Curci, Angela, et al.
Publicado: (2014)

Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia
por: Altamura, Concetta, et al.
Publicado: (2020)

Creatine as a Candidate to Prevent Statin Myopathy
por: Balestrino, Maurizio, et al.
Publicado: (2019)

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)
por: Parisi, Daniela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u74nt1v2vmdgm2mkgtnuqkc17v